Vice Chair of the Department of Medicine and medical oncologist in the Breast Medicine Service since 2006. Leads the TNBC Clinical Research Program and serves on the TBCRC TNBC working group. Member of the New York Metropolitan Breast Cancer Group and the editorial board of the European Journal of Clinical & Medical Oncology.

Dr Tiffany Traina has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Genentech/Roche, Pfizer, AstraZeneca, Merck, Daiichi Sankyo, Gilead Sciences, Tersera, Menarini Stemline, Exact Sciences, BioNTech SE, Veracyte, Aktis Oncology, Ellipses Pharma, and Astellas Pharma.